Basappa, N. S. (2016). Treatment options in advanced renal cell carcinoma after first-line treatment with vascular endothelial growth factor receptor tyrosine kinase inhibitors. Canadian Urological Association Journal, 10(11-12), S242–4. https://doi.org/10.5489/cuaj.4292